Journal Articles


*Denotes equal contribution  †Denotes corresponding author  **2020 JCR Impact Factor



28. Comprehensive characterization of distinct genetic alterations in metastatic breast cancer across various metastatic sites, Cha S, Lee E, Won HH† (2021), NPJ Breast Cancer**. 7(1):93, Doi: 10.1038/s41523-021-00303-y. PDF (**IF 6.923)

27. Bioengineered in vitro models of leukocyte-vascular interactions, Lee J, Breuer CB, Lee E (2021), Biochemical Society Transactions**. BST20200620. PDF (**IF 5.407)

26. Engineering three-dimensional vascularized cardiac tissues, Williams MAC, Mair DB, Lee W, Lee E, Kim DH† (2021), Tissue Engineering Part B: Reviews**. 10: 20142. PDF (**IF 6.389)


25. In vitro modeling of tumor spheroid interactions to perfused blood vessels, Kwak T, Lee E (2020), Scientific Reports. 10: 20142. PDF

24. Tissue-engineered models for glaucoma research, Lu R, Soden PA, Lee E (2020), Micromachines (Basel)**. 11(6), 612. PDF  **Feature Paper & Editor’s Choice

23. Rapid multilayer microfabrication for modeling organotropic metastasis in breast cancer, Kwak T, Lee E (2020), Biofabrication**. 13: 015002. PDF (**IF 9.954)


22. Blood and lymphatic vasculatures-on-chip platforms and their applications for organ-specific in vitro modeling, Henderson AR*, Choi H*, Lee E (2020), Micromachines (Basel). 11(2), 147. PDF



21. Biomimetic microsystems for blood and lymphatic vascular research, Nguyen DHT, Lee E (2019), Biomimetic Microengineering (CRC Press). page 36-60. PDF

20. A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling, Nguyen DHT*, Lee E*, Alimperti SA, Norgard RJ, Wong A, Lee JJK, Eyckmans J, Stanger BZ, Chen CS† (2019), Science Advances**. 5, eaav6789. PDF  (**IF 14.136)


Prior to Cornell

19. Biomimetic peptide display from a polymeric nanoparticle surface for targeting and antitumor activity to human triple-negative breast cancer cells. Bressler EM, Kim J, Shmueli RB, Mirando AC, Bazzazi H, Lee E, Popel AS, Pandey NB, Green JJ† (2018), Journal of Biomedical Materials Research A. 106(6):1753-1764. PDF


18. Human organ chip models recapitulate orthotopic lung cancer growth, therapeutic responses, and tumor dormancy in vitro. Hassell BA, Goyal G, Lee E, Sontheimer-Phelps A, Levy O, Chen CS, Ingber DE† (2018), Cell Reports**. 21(2):508-516. PDF  (**IF 9.423)


17. Laminar flow downregulates Notch activity to promote lymphatic sprouting. Choi D, Park E, Jung E, Seong YJ, Yoo J, Lee E, Hong M, Lee S, Ishida H, Burford J, Peti-Peterdi J, Adams RH, Srikanth S, Gwack Y, Chen CS, Vogel HJ, Koh CJ, Wong AK, Hong YK† (2017), Journal of Clinical Investigation**. 127(4):1225-1240. PDF  (**IF 14.808)

16. Biomimetic on-a-chip platforms for studying cancer metastasis, Lee E, Song HG, Chen CS† (2016), Current Opinion in Chemical Engineering**. 11:20-27. PDF (**IF 5.163)

15. The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts. Dore-Savard L, Lee E, Kakkad S, Popel AS, Bhujwalla ZM† (2016), Scientific Reports. 6:39460. PDF

14. Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumor and organ microenvironment. Lee E, Pandey NB, Popel AS† (2015), Expert Reviews in Molecular Medicine**. 17:e3. PDF (**IF 5.60)

13. Analysis of gene expression of secreted factors associated with breast cancer metastases in breast cancer subtypes. Fertig EJ*, Lee E*, Pandey NB, Popel AS† (2015), Scientific Reports. 5:12133. PDF   

12. Vasculature-specific MRI reveals differential anti-angiogenic effects of a biomimetic peptide in an orthotopic breast cancer model. Kim E, Lee E, Plummer C, Gil S, Popel AS, Pathak AP† (2015), Angiogenesis**. 18(2):125-36. PDF  (**IF 9.596)

11. Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis. Lee E, Fertig EJ, Jin K, Sukumar S, Pandey NB, Popel AS† (2014), Nature Communications**. 5:4715. PDF  (**IF 14.919)


10. Inhibition of breast cancer growth and metastasis by a biomimetic peptide. Lee E, Lee SJ, Koskimaki JE, Han Z, Pandey NB, Popel AS† (2014), Scientific Reports. 4:7139. PDF

9. Lymphatic endothelial cells support tumor growth in breast cancer. Lee E, Pandey NB, Popel AS† (2014), Scientific Reports. 4:5853. PDF

8. Pre-treatment of mice with tumor-conditioned media accelerates metastasis to lymph nodes and lungs: a new spontaneous breast cancer metastasis model. Lee E, Pandey NB, Popel AS† (2014), Clinical & Experimental Metastasis**. 31(1):67-79. PDF (**IF 5.150)

7. Angiogenesis interactome and time course microarray data reveal the distinct activation patterns in endothelial cells. Chu LH, Lee E, Bader JS, Popel AS† (2014), PLoS One. 9(10):e110871. PDF

6. A biomimetic collagen derived peptide exhibits anti-angiogenic activity in triple negative breast cancer. Rosca EV, Penet MF, Mori N, Koskimaki JE, Lee E, Pandey NB, Bhujwalla ZM, Popel AS† (2014), PLoS One. 9(11):e111901. PDF

5. Inhibition of lymphangiogenesis and angiogenesis in breast tumor xenografts and lymph nodes by a peptide derived from transmembrane protein 45A. Lee E, Koskimaki JE, Pandey NB, Popel AS† (2013), Neoplasia**. 15(2):112-24.PDF (**IF 5.715)


4. Synergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors. Koskimaki JE*, Lee E*, Chen W, Rivera CG, Rosca EV, Pandey NB, Popel AS† (2013), Angiogenesis**. 16 (1), 159-170. PDF  (**IF 9.596)

3. Serpin-derived peptides are antiangiogenic and suppress breast tumor xenograft growth. Koskimaki JE, Rosca EV, Rivera CG, Lee E, Chen W, Pandey NB, Popel AS† (2012), Translational Oncology. 5(2):92-7. PDF

2. Small peptides derived from somatotropin domain-containing proteins inhibit blood and lymphatic endothelial cell proliferation, migration, adhesion, and tube formation. Lee E*, Rosca EV*, Pandey NB, Popel AS† (2011), International Journal of Biochemistry & Cell Biology**. 43(12):1812-21. PDF (**IF 5.085)

1. Polyproline-type helical-structured low-molecular-weight heparin (LMWH)-taurocholate conjugate as a new angiogenesis inhibitor. Lee E*, Kim YS*, Bae SM, Kim SK, Jin S, Chung SW, Lee M, Moon HT, Jeon OC, Park RW, Kim IS, Byun Y†, Kim SY† (2009), International Journal of Cancer**. 124(12):2755-65. PDF (**IF 7.396)


2. Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis and lymphangiogenesis-dependent diseases. AS Popel, NB Pandey, E Lee, JJ Green, RB Shmueli (2017), US Patent 9,802,984.

1. Heparin conjugates and methods. Y Byun, ES Lee, O Jeon, SY Kim, RW Park (2012), US Patent 8,088,753.

Skip to toolbar